Gamma Medica-Ideas
Gamma Medica-Ideas develops novel technologies for markets that improve patient health through the early diagnosis of diseases
About Gamma Medica-Ideas
Gamma Medica-Ideas (GMI) operates in the medical technology sector, focusing on the development and manufacturing of advanced diagnostic imaging systems. The company was formed in June 2005 through the merger of Gamma Medica, based in Northridge, California, and Ideas ASA of Oslo, Norway. The integration of these two entities combined Gamma Medica's expertise in imaging systems with Ideas ASA's specialization in imaging detector subsystems. Bradley E. Patt, Ph.D., who was the CEO of Gamma Medica, became the president and CEO of the newly formed company. Thomas Langaard, the former general manager of Ideas, assumed the role of chief operating officer.
The company's business model revolves around designing, developing, and manufacturing next-generation imaging systems for diagnostic medicine, medical research, and safety applications. GMI's revenue is generated through the sale of these systems and by providing related services. Its client base includes medical researchers, pharmaceutical companies, hospitals, and diagnostic clinics. For instance, its pre-clinical systems are utilized by researchers to accelerate studies on disease progression and therapy effectiveness. The company established a global distribution network, with partners like GE Healthcare and SII NanoTechnology in Japan handling its pre-clinical products.
Gamma Medica-Ideas' product portfolio includes the LumaGEM® Molecular Breast Imaging (MBI) system and the FLEX Triumph™ pre-clinical imaging platform. The LumaGEM® system is designed for the early diagnosis of breast cancer, particularly in women with dense breast tissue, a demographic where traditional mammography can be less effective. This system utilizes dual-head Digital Direct Conversion Gamma Imaging™ (DDCGI™) technology with solid-state Cadmium Zinc Telluride (CZT) detectors to provide high-resolution images capable of identifying very small lesions. The FLEX Triumph™ is a versatile pre-clinical platform that can be configured with PET, SPECT, and CT subsystems, making it a tri-modality system. This modularity allows researchers to combine different imaging techniques in a single instrument for comprehensive studies. The company also had a history of adapting technology from other high-tech fields, such as space exploration, for medical and industrial applications.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Oct 2009 | $14M | $56M | Psilos Group · Capital Resource Partners | — |
Growth signals
Latest recorded traffic for Gamma Medica-Ideas is 70 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Gamma Medica-Ideas in the Los Angeles ecosystem
The Gamma Medica-Ideas office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Psilos Group
Capital Resource Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Gamma Medica-Ideas on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Gamma Medica-Ideas’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







